NZ185822A - Prostane derivatives and pharmaceutical compositions - Google Patents

Prostane derivatives and pharmaceutical compositions

Info

Publication number
NZ185822A
NZ185822A NZ185822A NZ18582277A NZ185822A NZ 185822 A NZ185822 A NZ 185822A NZ 185822 A NZ185822 A NZ 185822A NZ 18582277 A NZ18582277 A NZ 18582277A NZ 185822 A NZ185822 A NZ 185822A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
prostane derivatives
prostane
derivatives
pharmaceutical
Prior art date
Application number
NZ185822A
Other languages
English (en)
Inventor
Kh Gibson
Erh Walker
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NZ185822A publication Critical patent/NZ185822A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
NZ185822A 1976-12-08 1977-11-30 Prostane derivatives and pharmaceutical compositions NZ185822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (1)

Publication Number Publication Date
NZ185822A true NZ185822A (en) 1979-03-16

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185822A NZ185822A (en) 1976-12-08 1977-11-30 Prostane derivatives and pharmaceutical compositions

Country Status (14)

Country Link
JP (1) JPS5371060A (show.php)
AU (1) AU3104477A (show.php)
BE (1) BE861652A (show.php)
CA (1) CA1119591A (show.php)
DE (1) DE2754741A1 (show.php)
DK (1) DK548177A (show.php)
FR (1) FR2373538A1 (show.php)
GB (1) GB1550399A (show.php)
IE (1) IE46170B1 (show.php)
IT (1) IT1089433B (show.php)
NL (1) NL7713587A (show.php)
NZ (1) NZ185822A (show.php)
SE (1) SE7713895L (show.php)
ZA (1) ZA777059B (show.php)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (show.php) 1981-07-10
CA1119591A (en) 1982-03-09
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
IE46170B1 (en) 1983-03-09
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
DE2754741A1 (de) 1978-06-15
IE46170L (en) 1978-06-08
FR2373538A1 (fr) 1978-07-07
GB1550399A (en) 1979-08-15
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
PT66622A (en) Pharmaceutical compositions
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
AU3111677A (en) Pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185105A (en) Thiazolidine derivatives and pharmaceutical compositions
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ184281A (en) Hydantoin derivatives and pharmaceutical compositions
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
GB1547206A (en) Pharmaceutical compositions
PT66509B (en) Pharmaceutical compositions
NZ185295A (en) 9-chloroprednisolone derivatives and pharmaceutical compositions
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions
NZ184084A (en) 2-carboxyalkyl-pyrrolid-in or piperidin-one or-dione derivatives and pharmaceutical compositions